Trial Profile
A Phase 1, Open-label, Fixed-sequence Study To Estimate The Effects Of Multiple-dose Administration Of Itraconazole On The Pharmacokinetics Of Pf 04958242 In Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Itraconazole (Primary) ; Pesampator (Primary)
- Indications Cognition disorders
- Focus Pharmacokinetics
- Sponsors Biogen; Pfizer
- 23 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 22 Jan 2015 New trial record